Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left Main Coronary Artery Angioplasty vs. Surgery: A Large Meta-Analysis

Courtesy of Dr. Carlos Fava.

Left Main Coronary Artery Angioplasty vs. SurgeryAround 5% of patients undergoing coronary angiography present severe left main coronary artery (LMCA) lesions. Myocardial revascularization surgery (MRS) is the preferred method for this group, although there is evidence from different randomized trials demonstrating the safety and efficacy of unprotected LMCA angioplasty, with results similar to those obtained through the traditional strategy.

 

This analysis included data from 5 randomized studies (PRECOMBAT, SYNTAX, NOBLE, EXCEL, and a study carried out by Boudriot et al.) and 4594 patients.

 

The primary safety endpoint was defined as a composite of all-cause death, infarction, or stroke, and the secondary endpoint was a composite of all-cause death, infarction, stroke, and repeat revascularization.

 

The characteristics of both patient groups were well-balanced. There was no difference in the primary safety endpoint between strategies (odds ratio [OR]: 0.97; 95% confidence interval [CI]: 0.79-1.17; p = 0.73). In patients with complex coronary anatomy (SYNTAX >22), MRS was safer (OR: 1.64; 95% CI: 1.22-2.20; pinteraction = 0.006).

 

The secondary endpoint favored MRS because of significantly higher rates of repeat revascularization for the angioplasty group (OR: 1.85; 95% CI: 1.53-2.23; p <0.001). No differences were observed upon consideration of each individual component of the primary endpoint.

 

Conclusion

Angioplasty using drug-eluting stents and myocardial revascularization surgery are equally safe methods of revascularization for patients with less complex coronary anatomy and significant unprotected left main coronary artery lesions. However, surgery is associated with lower rates of repeat revascularization.

 

Editorial

This meta-analysis including the most modern randomized studies showed that angioplasty is as effective as surgery in patients with non-complex anatomy as defined by a SYNTAX <22 score.

 

While second-generation DES have been developed and complementary methods are applied during angioplasty (intravascular ultrasound [IVUS] vs. optical coherence tomography [OCT]), a higher need for revascularization continues to be the Achilles’ heel of angioplasty.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Original title: Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Stenosis. A Meta-Analysis of Randomized Trials.

Reference: Nitesh Nerlekar et al. Circ Cardiovasc Interv 2016;9e004729.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...